Armata Pharmaceuticals, Inc. (ARMP) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2015
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 4, 2026, Armata Pharmaceuticals, Inc. (ARMP) trades at a price-to-earnings ratio of -21.0x, with a stock price of $10.97 and trailing twelve-month earnings per share of $-1.29.
The current P/E is 308% below its 5-year average of 10.1x. Over the past five years, ARMP's P/E has ranged from a low of 1.4x to a high of 48.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.3x, ARMP trades at a 190% discount to its sector peers. The sector includes 225 companies with P/E ratios ranging from 0.0x to 190.3x.
Relative to the broader market, ARMP trades at a notable discount to the S&P 500 median P/E of 26.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ARMP DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2015 Q2 | $1309.00 | $27.11 | 48.3x | +380% | |
| FY2015 Q1 | $2065.00 | $273.51 | 7.5x | -25% | |
| FY2014 Q4 | Wed Dec 31 2014 00:00:00 GM | $1435.00 | $342.11 | 4.2x | -58% |
| FY2014 Q3 | $1512.00 | $793.20 | 1.9x | -81% | |
| FY2014 Q2 | Mon Jun 30 2014 00:00:00 GM | $3066.00 | $541.20 | 5.7x | -44% |
| FY2014 Q1 | Mon Mar 31 2014 00:00:00 GM | $4046.00 | $2768.58 | 1.5x | -85% |
| FY2013 Q4 | $3500.00 | $2576.36 | 1.4x | -86% |
Average P/E for displayed period: 10.1x
See ARMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARMP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARMP vs AGIO
See how ARMP stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARMP stock overvalued or undervalued?
ARMP trades at -21.0x P/E, below its 5-year average of 10.1x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ARMP's valuation compare to peers?
Armata Pharmaceuticals, Inc. P/E of -21.0x compares to sector median of 23.3x. The discount suggests lower growth expectations or higher risk.
What is ARMP's PEG ratio?
ARMP PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2015.